PACKAGE LEAFLET: INFORMATION FOR THE USER

Similar documents
Package leaflet: Information for the patient. Selenium 10 micrograms/ml concentrate for solution for infusion. Sodium selenite

PACKAGE LEAFLET: INFORMATION FOR THE USER

Package leaflet: Information for the patient Tranexamic acid 100 mg/ml Solution for Injection tranexamic acid

Package leaflet: Information for the user

Package leaflet: Information for the patient. NEGABAN 1g, powder for solution for injection or infusion Temocillin

1. What Miacalcic is and what it is used for

Package leaflet: Information for the user. Compound Macrogol Oral Powder Sugar Free

Package leaflet: Information for the user. Paralink 10 mg/ml Solution for Infusion Paracetamol

Package leaflet: Information for the patient. Paracetamol 10 mg/ml solution for infusion. Paracetamol

Package leaflet: Information for the user. <PRODUCT NAME> 10 g powder for oral solution in sachet Macrogol 4000

Package leaflet: Information for the user. {Product name} 100 mg/100 mg/1 mg/20 mg/2 ml solution for injection

Package Leaflet: Information for the user Laxido Paediatric Plain 6.9 g, powder for oral solution

Package leaflet: Information for the patient. Konakion MM Ampoules 10mg/ml solution for injection and oral solution Phytomenadione (vitamin K 1 )

Package leaflet: Information for the user. Calcium Folinate 10 mg/ml, solution for injection Calcium folinate

Package leaflet: Information for the user

Gammanorm, 165 mg/ml, solution for injection Human normal immunoglobulin

Fultium can also be used as an adjunct to specific bone loss medication

Package leaflet: Information for the user. Relestat, 0.5 mg/ml, eye drops, solution Epinastine hydrochloride

Patient Information Leaflet: Information for users

2. What you need to know before you are given Konakion MM. Package Leaflet: Information for the patient

Package leaflet: Information for the patient. Tranexamic Acid 100 mg/ml, Solution for Injection tranexamic acid

Package leaflet: Information for the user. Exembol 1 mg/ml solution for infusion. argatroban monohydrate

Package leaflet: Information for the user. Novastan 100 mg/ml concentrate for solution for infusion. argatroban monohydrate

Package leaflet: Information for the user. Bupivacaine 0.25% w/v, 0.5% w/v solution for injection Bupivacaine Hydrochloride

Package leaflet: Information for the user

Package leaflet: Information for the user. Lorastad 10 mg Tablets loratadine

PACKAGE LEAFLET: INFORMATION FOR THE USER. Cisatracurium 2 mg/ml solution for injection/infusion Cisatracurium 5 mg/ml solution for injection/infusion

PACKAGE LEAFLET: INFORMATION FOR THE USER. Actilyse Cathflo 2 mg, poeder voor oplossing voor injectie en infusie. Alteplase

Package leaflet: Information for the user. Elaprase 2 mg/ml concentrate for solution for infusion idursulfase

PACKAGE LEAFLET: INFORMATION FOR THE USER AMITIZA 24 MICROGRAM SOFT CAPSULES. Lubiprostone

PACKAGE LEAFLET: INFORMATION FOR THE USER. NALOXONE 400 microgram/ml solution for injection or infusion. naloxone hydrochloride

PATIENT INFORMATION LEAFLET

LEUCOVORIN-TEVA 10 mg/ml CONCENTRATE FOR SOLUTION FOR INFUSION folinic acid as the calcium salt PACKAGE LEAFLET: INFORMATION FOR THE USER

PACKAGE LEAFLET PACKAGE LEAFLET: INFORMATION FOR THE USER. chloroprocaine hydrochloride

PACKAGE LEAFLET: INFORMATION FOR THE USER. Human Albumin Biotest 20%, solution for infusion Human albumin

Ventolin Injection 500 micrograms/ml salbutamol sulfate

PACKAGE LEAFLET: INFORMATION FOR THE USER. Dopamine 40 mg/ml Sterile Concentrate

Package leaflet: Information for the user

Package leaflet: Information for the user. Carmellose sodium

Package leaflet: Information for the user. Lidocaine Hydrochloride 1% w/v Solution for Injection Lidocaine Hydrochloride

Sodium Chloride 0.9% w/v Intravenous Infusion BP Solution for Infusion Sodium chloride

THORENS I.U. /ml oral drops, solution Cholecalciferol (vitamin D 3 )

PACKAGE LEAFLET: INFORMATION FOR THE USER. Aspecton Cough Syrup. Thyme soft extract. For adults and children aged 1 year and older

PACKAGE LEAFLET: INFORMATION FOR THE USER. Active substance: enoximone

Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.

Patient Information Leaflet: Information for users

THORENS I.U. /2.5 ml oral solution. Cholecalciferol (vitamin D 3 )

PACKAGE LEAFLET: INFORMATION FOR THE USER. Calcium Folinate 10 mg/ml Injection

PACKAGE LEAFLET: INFORMATION FOR THE USER. Raloxifen STADA 60 mg film-coated tablets (raloxifene hydrochloride)

PACKAGE LEAFLET: INFORMATION FOR THE USER. octaplaslg mg/ml solution for infusion Human plasma proteins

Package leaflet: Information for the user. Aminoven 5% Solution for infusion Aminoven 10% Solution for infusion Aminoven 15% Solution for infusion

Package leaflet: Information for the user. Cefixime ABR 100 mg/5 ml powder for oral suspension Cefixime

Package leaflet: Information for the user. Omnilax 10 g powder for oral solution, sachet. Macrogol 4000

PACKAGE LEAFLET: INFORMATION FOR THE USER. Fibrovein 3%, 1%, 0.5% and 0.2% Solution for Injection Sodium tetradecyl sulphate

Package leaflet: Information for the user. HEPATECT CP 50 IU/ml solution for infusion. Human hepatitis B immunoglobulin for intravenous administration

Neuro-Medivitan is a vitamin preparation. Intended use Systemic neurological disorders due to proven deficiency of vitamins B1 and B6.

1. What Faslodex is and what it is used for

1. What Naropin is and what it is used for

Package leaflet: Information for the User Clarityn 1 mg/ml syrup Loratadine

Package Leaflet: Information for the user. LUMIGAN 0.3 mg/ml, eye drops, solution, in single-dose container Bimatoprost

PACKAGE LEAFLET: INFORMATION FOR THE USER. SODIPHOS 22mEq / 10ml Concentrate for solution for infusion. Disodium phosphate dihydrate

PACKAGE LEAFLET: INFORMATION FOR THE USER. Zoledronic Acid IBIGEN 4 mg powder and solvent for solution for infusion Zoledronic acid

D-Gam 250 micrograms/ml. Solution for injection. human anti-d immunoglobulin

Patient leaflet: Information for the user. Paracetamol Galpharm 500mg tablets paracetamol

Package leaflet: Information for the User Clarityn 10 mg tablets Loratadine

1. What Octostim Nasal Spray is and what it is used for

Package Leaflet: Information for the User. Glucosamine sulfate 750 mg Film-Coated Tablets

Package leaflet: Information for the user. Flutamid Stada 250 mg tablets Flutamide

PACKAGE LEAFLET: INFORMATION FOR THE USER. Metformin HCl Bluefish 500 mg/ 850 mg/ 1000 mg, film-coated tablets metformin hydrochloride

Package leaflet: Information for the patient. Trasylol 10,000 KIU/ml solution for injection or infusion. Aprotinin

CONSUMER MEDICINE INFORMATION LEAFLET

Package leaflet: Information for the user. Dalmevin 50 mg tablets Vildagliptin

Package leaflet: Information for the patient. Lacosamide G.L. 10 mg/ml solution for infusion lacosamide

Package Leaflet: Information for the User

Package leaflet: Information for the user. Entecavir Alvogen 0,5 mg filmomhulde tabletten Entecavir Alvogen 1 mg filmomhulde tabletten Entecavir

Package leaflet: Information for the patient

Package leaflet: Information for the user. Rhesonativ 625 IU/ml, solution for injection Human anti-d immunoglobulin

Package leaflet: Information for the user

Package leaflet: Information for the user Cyklokapron 500 mg Solution for Injection tranexamic acid

Package leaflet: Information for the patient

Package leaflet: Information for the user. Portrazza 800 mg concentrate for solution for infusion necitumumab

The medicines you are using mixed with Water for injections may interact with each other.

Package leaflet: Information for the user Phosex 1000 mg Tablets Calcium acetate

Proposed PIL NL/H/0653/001/IB/024/G. MONOFREE DEXAMETHASON 1 mg/ml, eye drops, solution in single-dose container Dexamethasone phosphate

Package leaflet: Information for the patient

Package leaflet: Information for the patient. Bromhexin Krewel Meuselbach Drops 12 mg/ml. Bromhexine hydrochloride

Package leaflet: information for the user. Memantine STADA 20 mg filmomhulde tabletten. Memantine hydrochloride

Azelastine Nasal Spray 1 mg / 1 ml

Irbenida 150 mg film-coated tablets; 300 mg film-coated tablets

Package leaflet: Information for the patient. Bumetanide 1 mg and 5 mg Tablets (bumetanide)

Package leaflet: Information for the patient. Leucovorine Sandoz 10 mg/ml, oplossing voor injectie folinic acid

Package leaflet: Information for the patient. Calcium Folinate 15 mg Tablets calcium folinate

Package leaflet: Information for the patient. ERWINASE 10,000 Units, Powder for solution for injection

PACKAGE LEAFLET: INFORMATION FOR THE USER. Glucose Intravenous Infusion BP 10% w/v solution for infusion Glucose (as glucose monohydrate)

Package leaflet: Information for the patient. / / 30 mg/5 ml syrup. Ambroxol hydrochloride

Package leaflet: Information for the user. Chirocaine mg/ml or 1.25 mg/ml solution for infusion For epidural use only.

PATIENT / USER INFORMATION LEAFLET. Cinryze 500 Units powder and solvent for solution for injection C1 inhibitor (human)

PACKAGE LEAFLET: INFORMATION FOR THE USER. <PRODUCT NAME> 600 mg / 1,000 IU orodispersible tablets. Calcium/cholecalciferol (Vitamin D3)

Package leaflet: Information for the user. Colecalciferol 3000 IU/ml Oral Solution (colecalciferol)

Package leaflet: Information for the patient

Transcription:

biosyn Arzneimittel GmbH Schorndorfer Strasse 32, 70734 Fellbach, Germany PACKAGE LEAFLET: INFORMATION FOR THE USER Selenase 100 micrograms, solution for injection (50 micrograms/ml) 100 microgram selenium per 2 ml solution for injection Selenase 500 micrograms, solution for injection (50 micrograms/ml) 500 microgram selenium per 10 ml solution for injection Active substance: Sodium selenite pentahydrate Read all of this leaflet carefully before you start using this medicine. - Keep this leaflet. You may need to read it again. - If you have any further questions, ask your doctor or pharmacist. - This medicine has been prescribed for you. Do not pass it on to others. It may harm them, even if their symptoms are the same as yours. - If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, please tell your doctor or pharmacist. In this leaflet: 1. What Selenase solution for injection is and what it is used for 2. Before you use Selenase solution for injection 3. How to use Selenase solution for injection 4. Possible side effects 5. How to store Selenase solution for injection 6. Further information 1. WHAT SELENASE SOLUTION FOR INJECTION IS AND WHAT IT IS USED FOR Selenase solution for injection is a medicinal product which belongs to the group of the mineral supplements. Sodium selenite pentahydrate, the active substance in your solution for injection, provides a source of selenium, which is an essential trace element in nutrition to ensure that your metabolism functions efficiently. Your doctor will have recommended this medicine because tests to measure the selenium levels in your blood have shown that you have a selenium deficiency, which cannot be corrected by selenium intake from food sources. selenase solution for injection PIL (July 2015) Page 1/6 Version 0010 1.3.1.3 Package Leaflet en Page 1

2. BEFORE YOU USE SELENASE SOLUTION FOR INJECTION Do not use Selenase solution for injection - if you are allergic (hypersensitive) to sodium selenite pentahydrate or any of the other ingredients of Selenase solution for injection. - if you have a selenosis (selenium poisoning). Take special care with Selenase solution for injection There are no special warnings or precautions for the use of Selenase solution for injection. Using other medicines Please tell your doctor or pharmacist if you are taking or have recently taken any other medicines, including medicines obtained without a prescription. It must be ensured that the solution is not mixed with reducing substances (e.g. vitamin C). Pregnancy and breast-feeding Ask your doctor or pharmacist for advice before taking any medicine. Pregnancy: There are no data from the use of Selenase solution for injection in pregnant women. No adverse effect of sodium selenite on the pregnancy or the unborn child is expected, provided that it is used in case of proven selenium deficiency. Breast-feeding: Selenium is excreted into the breast milk. But doses correcting selenium deficiency in breast-feeding women are not expected to exert adverse effects on the breast-feeded infant. Driving and using machines There is no effect on the ability to drive and use machines. Important information about some of the ingredients of Selenase solution for injection Selenase solution for injection contains less than 1 mmol sodium (23 mg) per ml, therefore it is essentially sodium free. 3. HOW TO USE SELENASE SOLUTION FOR INJECTION Always use medicinal products exactly as your doctor has told you. You should check with your doctor or pharmacist if you are not sure. Selenase solution for injection is for single use only. The usual daily dose is: 100 200 micrograms selenium (equivalent to 1 to 2 ampoules Selenase 100 micrograms, solution for injection or 2 4 ml Selenase 500 micrograms, solution for injection). selenase solution for injection PIL (July 2015) Page 2/6 Version 0010 1.3.1.3 Package Leaflet en Page 2

If the results from a blood test show that more selenium is required your doctor can increase the dose up to 500 micrograms selenium (equivalent to 5 ampoules Selenase 100 micrograms, solution for injection or 1 injection vial Selenase 500 micrograms, solution for injection). Method of administration: Selenase solution for injection is always administered to you by a nurse or a doctor. Selenase solution for injection is administered as an intramuscular (injection into the muscles) or intravenous (injection into a vein) injection. Duration of treatment: Samples of your blood will be taken from time to time and used to determine the levels of selenium in your blood in order to monitor the success of your treatment. As soon as your selenium levels will be normal your treatment with Selenase solution for injection will be finished. Dosage in children If you are a child your doctor will prescribe you a dose of 2 µg/kg body weight per day at therapy onset and a maintenance dose of 1 µg/kg body weight per day. Samples of your blood will be taken from time to time and used to determine the levels of selenium in your blood in order to monitor the success of your treatment. In the table below you can find the maximum daily doses for children for a longer time: Age (years) Tolerable Upper Intake Level (µg selenium/day) 1-3 60 4-6 90 7-10 130 11-14 200 15-17 250 Dosage in patients with renal or hepatic impairment: Your doctor will not prescribe a different dose if you have renal or hepatic impairment. If you use more Selenase solution for injection than you should If you use more Selenase solution for injection than you should the following symptoms may occur: acute (short-term): odour of garlic on the breath, tiredness, nausea, diarrhoea and abdominal pain or chronic (long-term) what can affect the growth of nails and hair and may lead to peripheral polyneuropathy (a disorder of a nerve or nervous pathway that may be associated with numbness or thingling). If you forget to use Selenase solution for injection Do not use a double dose to make up for a forgotten injection. If you stop using Selenase solution for injection There are no special instructions, if you stop using Selenase solution for injection. If you have any further questions on the use of this product, ask your doctor or pharmacist. selenase solution for injection PIL (July 2015) Page 3/6 Version 0010 1.3.1.3 Package Leaflet en Page 3

4. POSSIBLE SIDE EFFECTS Like all medicines, Selenase solution for injection can cause side effects, although not everybody gets them. Frequency not known (cannot be estimated from the available data): After intramuscular administration you may feel pain at the place, where your nurse or doctor has administered Selenase solution for injection. However, if you are given too much, the symptoms listed in the above section may be experienced. Reporting of side effects If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via <to be completed nationally>. By reporting side effects you can help provide more information on the safety of this medicine. 5. HOW TO STORE SELENASE SOLUTION FOR INJECTION Keep out of the reach and sight of children. The nurse or doctor will administer you this medicine immediately after opening the ampoules or the vials. The nurse or doctor will not administer you this medicine if the ampoule or the vial is damaged or if the solution is cloudy. This medicinal product does not require any special storage conditions. Do not use Selenase solution for injection after the expiry date which is stated on the label on the ampoule or the vial and on the carton after EXP. The expiry date refers to the last day of that month. 6. FURTHER INFORMATION What Selenase solution for injection contains The active substance is: Sodium selenite pentahydrate The other ingredients are: Sodium chloride, hydrochloric acid, water for injections - Selenase 100 micrograms, solution for injection: Each 2 ml injection ampoule contains 100 micrograms selenium in the form of 333 micrograms sodium selenite pentahydrate, corresponding to 50 micrograms/ml. selenase solution for injection PIL (July 2015) Page 4/6 Version 0010 1.3.1.3 Package Leaflet en Page 4

- Selenase 500 micrograms, solution for injection: Each 10 ml injection vial contains 500 micrograms selenium in the form of 1,665 micrograms sodium selenite pentahydrate, corresponding to 50 micrograms/ml. What Selenase solution for injection looks like and contents of the pack What Selenase solution for injection looks like: Selenase solution for injection is a clear and colourless solution. Contents of the pack: - Selenase 100 micrograms, solution for injection: Injection ampoules each containing 2 ml of injection solution are made of glass. Pack sizes: 5, 10 and 50. - Selenase 500 micrograms, solution for injection: Injection vials each containing 10 ml of solution for injection are made of glass with a rubber stopper. Pack sizes: 2 and 10. Not all pack sizes may be marketed. Marketing Authorisation Holder and Manufacturer biosyn Arzneimittel GmbH Schorndorfer Strasse 32 70734 Fellbach Germany This medicinal product is authorised in the Member States of the EEA under the following names: NL: selenase oplossing voor injectie 100 µg, oplossing voor injectie 50 µg/ml selenase oplossing voor injectie 500 µg, oplossing voor injectie 50 µg/ml CZ: selenase inječní roztok 500 µg, inječní roztok 50 µg/ml HU: selesyn 100 microgramm, oldatos injekció selesyn 500 microgramm, oldatos injekció IE: selesyn 100 micrograms, 2 ml solution for injection (50 micrograms/ml) selesyn 500 micrograms, 10 ml solution for injection (50 micrograms/ml) IT: selesyn 100 mcg soluzione iniettabile selesyn 500 mcg soluzione iniettabile PT: selenase solução injectável 100 microgramas selenase solução injectável 500 microgramas SK: selenase inječný roztok 100 µg, inječný roztok 50 µg/ml selenase inječný roztok 500 µg, inječný roztok 50 µg/ml UK: selenase 100 micrograms, solution for injection (50 micrograms/ml) selenase 500 micrograms, solution for injection (50 micrograms/ml) This leaflet was last approved in 07/2015. Further information for the medicinal staff When preparing an infusion solution with Selenase solution for injection as a supplement, it must be ensured that the ph value does not fall below 7.0 and that the solution is not mixed with reducing substances (e.g. vitamin C), as a precipitate of elemental selenium selenase solution for injection PIL (July 2015) Page 5/6 Version 0010 1.3.1.3 Package Leaflet en Page 5

may possibly result. On grounds of safety, non-specific precipitation should be avoided after mixing infusion solutions with Selenase solution for injection. Elemental selenium is not soluble in an aqueous medium and has no biological availability. When Selenase solution for injection is administered as a supplement to general infusion solutions for total parenteral nutrition, a daily dose of 100 micrograms selenium (1 ampoule Selenase 100 micrograms, solution for injection) must be ensured. There is no time limit to the administration of Selenase solution for injection in a supplementary dose (100 micrograms selenium per day = 1 ampoule Selenase 100 micrograms, solution for injection). Selenium levels in the whole blood or serum should be determined in order to monitor the success of the therapy. Selenase solution for injection may be mixed with 0.9% NaCl. This medicinal product does not require any special storage conditions. The shelf-life of Selenase solution for injection in the unopened ampoules or vials is 4 years. Discard any unused contents. selenase solution for injection PIL (July 2015) Page 6/6 Version 0010 1.3.1.3 Package Leaflet en Page 6